У нас вы можете посмотреть бесплатно ADAI Symposium: Short and Long-Term Risks of High-THC Products (AM Panel) или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
The Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington hosted the "High-THC Cannabis in Legal Regulated Markets" symposium on September 16, 2022. This event was held for the public, researchers, policymakers, and other stakeholders to learn about the short and long-term risks of high-THC products, including conversations about policy-focused solutions and ways to increase awareness through education campaigns for providers, parents, and youth. Speakers include a range of international, national, and regional experts. This video features the AM panel discussion: Introductions: State Rep. Lauren Davis (D-Shoreline) Moderator: Tracy Klein, PhD, ARNP, FAANP, FRE, FAAN 0:00:00-0:00:47 Introduction "High-THC Products: Public Health Outcomes in Legal Markets" 0:00:47-0:20:55 Julia Dilley, PhD "Acute Effects of High-Potency Cannabis Flower and Concentrates on Cognition" 0:20:55-0:43:43 Carrie Cuttler, PhD "Cannabis Use by Young Adults: Trends and Considerations" 0:43:43-1:04:27 Jason Kilmer, PhD "Cannabis Use & Psychiatric Comorbidity: Epidemiology & Association with High-Potency Cannabis" 1:04:27-1:23:19 Deborah Hasin, PhD "Recommendations for Regulating High-Potency Cannabis in Recreational Markets and Why" 1:23:19-1:50:00 Rosalie Pacula, PhD 1:50:00-2:04:10 Panel Q&A ----------------------------------------------------------- Watch the full event here: • ADAI Symposium: High-THC Cannabis in Legal... This symposium’s focus was on high-THC products sold for non-medical use in the market regulated by the WSLCB. The use of cannabis as a medicine should be decided by individuals and their health care providers.